featured
Upfront FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study
J. Clin. Oncol 2024 Jun 12;[EPub Ahead of Print], C Antoniotti, D Rossini, F Pietrantonio, L Salvatore, S Lonardi, S Tamberi, F Marmorino, R Moretto, M Prisciandaro, E Tamburini, G Tortora, A Passardi, F Bergamo, A Raimondi, G Ritorto, B Borelli, V Conca, C Ugolini, G Aprile, L Antonuzzo, F Gelsomino, E Martinelli, N Pella, G Masi, L Boni, J Galon, C CremoliniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.